Institutional Ownership Dyne Therapeutics, Inc. (DYN)
This table provides information about the institutional ownership of Dyne Therapeutics, Inc. (DYN). We have compiled data on the 211 institutions that hold shares in the stock, with a total of 122 Million shares, which have been reported (via 13F filing form) to have a value of $1.62 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Ra Capital Management, L.P.
Boston, MA |
Aug 14, 2025 Q2 2025 |
9,714,392
shares
|
$129 Million
2.02% of portfolio
|
Q1 2025
Added 52.24%
|
|
|
Janus Henderson Group PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
9,437,962
shares
|
$125 Million
0.05% of portfolio
|
Q2 2025
Reduced 8.84%
|
|
|
Atlas Venture Life Science Advisors, LLC
|
Aug 12, 2025 Q2 2025 |
9,130,465
shares
|
$121 Million
19.12% of portfolio
|
Q1 2025
Added 13.86%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
7,651,157
shares
|
$101 Million
0.0% of portfolio
|
Q2 2025
Added 3.31%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
7,386,988
shares
|
$97.9 Million
0.01% of portfolio
|
Q2 2024
Added 37.05%
|
|
|
Fcpm Iii Services B.V.
Naarden, P7 |
Aug 14, 2025 Q2 2025 |
5,462,846
shares
|
$72.4 Million
14.09% of portfolio
|
Q4 2024
Reduced 8.25%
|
|
|
Siren, L.L.C.
New York, NY |
Aug 13, 2025 Q2 2025 |
4,836,437
shares
|
$64.1 Million
2.38% of portfolio
|
Q2 2025
Added 77.94%
|
|
|
Tcg Crossover Management, LLC
Palo Alto, CA |
Aug 14, 2025 Q2 2025 |
3,766,660
shares
|
$49.9 Million
7.31% of portfolio
|
Q2 2025
Added 42.13%
|
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
3,355,678
shares
|
$44.5 Million
0.0% of portfolio
|
Q2 2025
Reduced 7.04%
|
|
|
Braidwell LP
Stamford, CT |
Aug 14, 2025 Q2 2025 |
3,273,349
shares
|
$43.4 Million
1.91% of portfolio
|
Q2 2025
Reduced 9.61%
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Aug 14, 2025 Q2 2025 |
3,191,000
shares
|
$42.3 Million
0.05% of portfolio
|
Q2 2025
New holding
|
|
|
Armistice Capital, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
2,560,000
shares
|
$33.9 Million
0.43% of portfolio
|
Q2 2025
Reduced 7.51%
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
2,531,313
shares
|
$33.5 Million
0.0% of portfolio
|
Q1 2025
Added 2472.81%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
2,383,953
shares
|
$31.6 Million
0.0% of portfolio
|
Q2 2025
Added 30.96%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
2,253,670
shares
|
$29.9 Million
0.0% of portfolio
|
Q2 2025
Added 15.25%
|
|
|
Perceptive Advisors LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
2,247,390
shares
|
$29.8 Million
0.94% of portfolio
|
Q2 2025
Reduced 2.85%
|
|
|
Vr Adviser, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
2,173,913
shares
|
$28.8 Million
4.1% of portfolio
|
Q2 2023
New holding
|
|
|
Logos Global Management LP
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
1,900,000
shares
|
$25.2 Million
2.34% of portfolio
|
Q2 2025
Added 280.0%
|
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
1,793,590
shares
|
$23.8 Million
0.01% of portfolio
|
Q2 2025
Added 53.56%
|
|
|
Rtw Investments, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
1,690,567
shares
|
$22.4 Million
0.25% of portfolio
|
Q1 2025
Reduced 67.61%
|
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Aug 14, 2025 Q2 2025 |
1,505,984
shares
|
$20 Million
0.76% of portfolio
|
Q2 2025
Added 4.34%
|
|
|
Saturn V Capital Management LLC
Austin, TX |
Aug 13, 2025 Q2 2025 |
1,455,429
shares
|
$19.3 Million
5.62% of portfolio
|
Q2 2025
New holding
|
|
|
Bio Impact Capital LLC
Cambridge, MA |
Aug 14, 2025 Q2 2025 |
1,446,361
shares
|
$19.2 Million
2.7% of portfolio
|
Q2 2025
New holding
|
|
|
Franklin Resources Inc
San Mateo, CA |
Aug 12, 2025 Q2 2025 |
1,390,140
shares
|
$18.4 Million
0.0% of portfolio
|
Q2 2025
Reduced 1.75%
|
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
1,362,176
shares
|
$18 Million
0.0% of portfolio
|
Q2 2025
Reduced 2.11%
|